Clinical Trials
3 trialsNCT04081389 2023-09-11
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT03599453 2023-07-18
Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT03066947 2021-01-29
SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
BriaCell Therapeutics Corporation
Phase 1/2 Completed